iCAD announced the expansion of its sales leadership with the addition of Peter Graham, as Senior Vice President, North American Sales and a role change for Bill Keyes to Senior Vice President, Global Sales Operations, both effective immediately. Since joining iCAD in December of 2022, Bill Keyes has developed and deployed sales processes and procedures to organize a more streamlined sales operation and provide for a deeper view of iCAD’s customers and areas for growth. In his new role, Keyes will continue to provide sales operation guidance in North America and beyond, while building partnerships and business strategies for global growth. Peter Graham is assuming responsibilities for revenue growth across North America, bringing more than 20 years of experience in the breast health, diagnostic, and medical solutions space including roles at Tempus Labs, Arterys, Volpara and Xoft. Under Peter’s leadership, iCAD will be adding sales staff to support its growth.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ICAD:
- iCAD announces AI solutions to be offered in new MyBreastAI offering
- iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
- iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
- iCAD to present new studies on ProFound Breast Health Suite
- iCAD, CancerIQ announce partnership to integrate AI-enabled technology